Determinants of iron accumulation in deep grey matter of multiple sclerosis patients

Multiple Sclerosis Journal

Volumn 20, Issue 13, 2014, Pages 1692-1698

  Ropele, Stefan ^a   Kilsdonk, Iris D ^b   Wattjes, Mike P ^b   Langkammer, Christian ^a   De Graaf, Wolter L ^b   Frederiksen, Jette L ^c   Larsson, Henrik B ^c   Yiannakas, Marios ^d   Wheeler Kingshott, Claudia A M ^d   Enzinger, Christian ^a   Khalil, Michael ^a   Rocca, Maria A ^e   Sprenger, Till ^f   Amann, Michael ^f   Kappos, Ludwig ^f   Filippi, Massimo ^e   Rovira, Alex ^g   Ciccarelli, Olga ^d   Barkhof, Frederik ^b   Fazekas, Franz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Age; Brain; Brain volume; Deep grey matter; Disease duration; Expanded Disability Status Scale; Iron; Multiple sclerosis; R2

Indexed keywords

IRON;

ADULT; AGE; AGED; ARTICLE; BRAIN MAPPING; BRAIN SIZE; CAUDATE NUCLEUS; COMPARATIVE STUDY; DENTATE NUCLEUS; DISABILITY; DISEASE COURSE; DISEASE DURATION; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RED NUCLEUS; SUBSTANTIA NIGRA; ADOLESCENT; CONTROLLED STUDY; BRAIN; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; BRAIN; FEMALE; GRAY MATTER; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; YOUNG ADULT;

EID: 84911432961     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514531085     Document Type: Article

References (31)

1. Bakshi R, Shaikh ZA and Janardhan V. MRI T2 shortening ('black T2') in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000; 11: 15-21.
2. Bakshi R, Benedict RHB, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: A quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62-68.
3. Zhang Y, Zabad RK, Wei X, et al. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007; 13: 880-883.
4. Ceccarelli A, Filippi M, Neema M, et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler 2009; 15: 678-686.
5. Hammond KE, Lupo JM, Xu D, et al. Development of a robust method for generating 7.0 T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. Neuroimage 2008; 39: 1682-1692.
6. Khalil M, Langkammer C, Ropele S, et al. Determinants of brain iron in multiple sclerosis: A quantitative 3T MRI study. Neurology 2011; 77: 1691-1697.
7. ∗ relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009; 15: 1048-1054.
8. Zivadinov R, Heininen-Brown M, Schirda CV, et al. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: A case-control study. Neuroimage 2012; 59: 331-339.
9. Craelius W, Migdal MW, Luessenhop CP, et al. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 1982; 106: 397-399.
10. LeVine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 1997; 760: 298-303.
11. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009; 29: 537-544.
12. Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: A combined imaging and histopathological study at 7 Tesla. Brain 2011; 134: 3602-3615.
13. Wiggermann V, Hernández Torres E, Vavasour IM, et al. Magnetic resonance frequency shifts during acute MS lesion formation. Neurology 2013; 81: 211-218.
14. Hametner S, Wimmer I, Haider L, et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 2013; 74: 848-861.
15. Hagemeier J, Weinstock-Guttman B, et al. Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy. AJNR Am J Neuroradiol 2012; 33: 1596-1601.
16. Ropele S, de Graaf W, Khalil M, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011; 34: 13-21.
17. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: A postmortem validation study. Radiology 2010; 257: 455-462.
18. Walsh AJ, Lebel RM, Eissa A, et al. Multiple sclerosis: Validation of MR imaging for quantification and detection of iron. Radiology 2013; 267: 531-542.
19. Hallgren B and Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3: 41-51.
20. Jueptner M, Frith CD, Brooks DJ, et al. Anatomy of motor learning. II. Subcortical structures and learning by trial and error. J Neurophysiol 1997; 77: 1325-1337.
21. Lehéricy S, Bardinet E, Tremblay L, et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cereb Cortex 2006; 16: 149-161.
22. ∗ mapping in the healthy brain. Magn Reson Med 2014; 71:1103-1107.
23. Schweser F, Sommer K, Deistung A, et al. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 2012; 62: 2083-2100.
24. Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012; 59: 2560-2568.
25. Connor JR and Benkovic SA. Iron regulation in the brain: Histochemical, biochemical, and molecular considerations. Ann Neurol 1992; 32: S51-S61.
26. Crichton RR, Wilmet S, Legssyer R, et al. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 2002; 91: 9-18.
27. Todorich B, Zhang X, Slagle-Webb B, et al. Tim-2 is the receptor for H-ferritin on oligodendrocytes. J Neurochem 2008; 107: 1495-1505.
28. Morris CM, Keith AB, Edwardson JA, et al. Uptake and distribution of iron and transferrin in the adult rat brain. J Neurochem 1992; 59: 300-306.
29. Taylor EM, Crowe A and Morgan EH. Transferrin and iron uptake by the brain: Effects of altered iron status. J Neurochem 1991; 57: 1584-1592.
30. He X and Yablonskiy DA. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc Natl Acad Sci U S A 2009; 106: 13558-13563.
31. Li W, Wu B, Avram A V, et al. Magnetic susceptibility anisotropy of human brain in vivo and its molecular underpinnings. Neuroimage 2012; 59: 2088-2097.